As Sangamo Therapeutics (SGMO) Stock Price Rose, Altrinsic Global Advisors Decreased Position; As Weibo (WB) Share Price Rose, Holder Parametrica Management LTD Raised Holding

February 15, 2018 - By Henry Gaston

Parametrica Management Ltd increased its stake in Weibo Corp (WB) by 814.61% based on its latest 2017Q3 regulatory filing with the SEC. Parametrica Management Ltd bought 97,631 shares as the company’s stock rose 41.58% with the market. The institutional investor held 109,616 shares of the programming company at the end of 2017Q3, valued at $10.85 million, up from 11,985 at the end of the previous reported quarter. Parametrica Management Ltd who had been investing in Weibo Corp for a number of months, seems to be bullish on the $30.15 billion market cap company. The stock decreased 2.39% or $3.34 during the last trading session, reaching $136.3. About 1.98 million shares traded or 6.43% up from the average. Weibo Corporation (NASDAQ:WB) has risen 239.00% since February 15, 2017 and is uptrending. It has outperformed by 222.30% the S&P500.

Altrinsic Global Advisors Llc decreased its stake in Sangamo Therapeutics Inc (SGMO) by 6.9% based on its latest 2017Q3 regulatory filing with the SEC. Altrinsic Global Advisors Llc sold 40,000 shares as the company’s stock rose 95.00% with the market. The institutional investor held 540,000 shares of the health care company at the end of 2017Q3, valued at $8.10M, down from 580,000 at the end of the previous reported quarter. Altrinsic Global Advisors Llc who had been investing in Sangamo Therapeutics Inc for a number of months, seems to be less bullish one the $1.86 billion market cap company. The stock decreased 2.22% or $0.5 during the last trading session, reaching $22.05. About 979,896 shares traded. Sangamo Therapeutics, Inc. (NASDAQ:SGMO) has risen 29.78% since February 15, 2017 and is uptrending. It has outperformed by 13.08% the S&P500.

Parametrica Management Ltd, which manages about $237.39M US Long portfolio, decreased its stake in Amerco (NASDAQ:UHAL) by 1,183 shares to 1,227 shares, valued at $460,000 in 2017Q3, according to the filing.

Among 11 analysts covering Weibo Corp (NASDAQ:WB), 8 have Buy rating, 0 Sell and 3 Hold. Therefore 73% are positive. Weibo Corp had 21 analyst reports since August 19, 2015 according to SRatingsIntel. The stock has “Neutral” rating by Goldman Sachs on Monday, May 16. Barclays Capital maintained the stock with “Buy” rating in Wednesday, February 14 report. The firm has “Buy” rating given on Tuesday, January 2 by UBS. As per Wednesday, November 15, the company rating was maintained by Barclays Capital. On Thursday, December 17 the stock rating was upgraded by Morgan Stanley to “Overweight”. The rating was reinitiated by JP Morgan with “Overweight” on Wednesday, August 31. The stock has “Hold” rating by Zacks on Friday, September 4. Jefferies maintained it with “Buy” rating and $105.0 target in Tuesday, October 3 report. The stock of Weibo Corporation (NASDAQ:WB) earned “Overweight” rating by Morgan Stanley on Tuesday, April 19. The stock has “Buy” rating by Jefferies on Tuesday, January 23.

Investors sentiment decreased to 1.55 in 2017 Q3. Its down 1.07, from 2.62 in 2017Q2. It dived, as 40 investors sold WB shares while 48 reduced holdings. 48 funds opened positions while 88 raised stakes. 125.34 million shares or 324.34% more from 29.54 million shares in 2017Q2 were reported. Firsthand Mgmt Inc holds 0.26% in Weibo Corporation (NASDAQ:WB) or 3,000 shares. Zurcher Kantonalbank (Zurich Cantonalbank) has invested 0.01% in Weibo Corporation (NASDAQ:WB). Aperio Ltd Llc reported 35,734 shares. Pinnacle Finance Partners Inc has invested 0.03% in Weibo Corporation (NASDAQ:WB). Ameriprise Fincl Incorporated holds 0% of its portfolio in Weibo Corporation (NASDAQ:WB) for 40,414 shares. Asset Management invested in 6,783 shares. Advisors Asset Management, Colorado-based fund reported 30,758 shares. Los Angeles Cap Equity Rech Inc invested 0.05% of its portfolio in Weibo Corporation (NASDAQ:WB). Profund Advsr Ltd Company reported 9,020 shares stake. The Virginia-based Thompson Davis Company Inc has invested 0.02% in Weibo Corporation (NASDAQ:WB). Great West Life Assurance Can stated it has 19,772 shares. Bnp Paribas Arbitrage holds 0.04% or 170,244 shares in its portfolio. 1,655 are held by Castleark Ltd. Canada Pension Plan Investment Board has 0% invested in Weibo Corporation (NASDAQ:WB) for 10 shares. Global X Mgmt Ltd Com stated it has 120,167 shares.

Since September 1, 2017, it had 0 insider purchases, and 8 sales for $1.88 million activity. On Friday, September 1 Herberts Curt A. III sold $225,000 worth of Sangamo Therapeutics, Inc. (NASDAQ:SGMO) or 15,000 shares. RINGO WILLIAM R sold $445,597 worth of stock. The insider Mento Steven J sold $237,159.

Analysts await Sangamo Therapeutics, Inc. (NASDAQ:SGMO) to report earnings on February, 27. They expect $-0.18 EPS, down 28.57% or $0.04 from last year’s $-0.14 per share. After $-0.15 actual EPS reported by Sangamo Therapeutics, Inc. for the previous quarter, Wall Street now forecasts 20.00% negative EPS growth.

Among 10 analysts covering Sangamo Biosciences (NASDAQ:SGMO), 7 have Buy rating, 1 Sell and 2 Hold. Therefore 70% are positive. Sangamo Biosciences had 22 analyst reports since August 8, 2015 according to SRatingsIntel. Piper Jaffray maintained Sangamo Therapeutics, Inc. (NASDAQ:SGMO) rating on Wednesday, January 3. Piper Jaffray has “Buy” rating and $25.0 target. On Friday, October 23 the stock rating was reinitiated by Jefferies with “Buy”. Jefferies maintained the stock with “Buy” rating in Tuesday, September 12 report. Jefferies reinitiated Sangamo Therapeutics, Inc. (NASDAQ:SGMO) rating on Thursday, June 22. Jefferies has “Buy” rating and $1700 target. Janney Capital downgraded Sangamo Therapeutics, Inc. (NASDAQ:SGMO) on Thursday, August 4 to “Neutral” rating. The firm earned “Neutral” rating on Wednesday, October 19 by Piper Jaffray. The stock has “Buy” rating by Cowen & Co on Friday, September 4. On Friday, December 4 the stock rating was initiated by Wells Fargo with “Outperform”. The rating was downgraded by PiperJaffray to “Neutral” on Wednesday, October 19. The stock of Sangamo Therapeutics, Inc. (NASDAQ:SGMO) has “Buy” rating given on Thursday, September 3 by JP Morgan.

Altrinsic Global Advisors Llc, which manages about $14.11 billion and $2.64B US Long portfolio, upped its stake in Seaspine Hldgs Corp by 98,861 shares to 545,201 shares, valued at $6.12 million in 2017Q3, according to the filing. It also increased its holding in Kindred Healthcare Inc (NYSE:KND) by 100,000 shares in the quarter, for a total of 637,000 shares, and has risen its stake in Intercept Pharmaceuticals In (NASDAQ:ICPT).

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.





Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: